332 related articles for article (PubMed ID: 18803676)
1. Placental production and maternal serum and urine levels of inhibin A and activin A are modified by antihypertensive therapy in hypertensive disorders of pregnancy.
Khalil A; Jauniaux E; Harrington K; Muttukrishna S
Clin Endocrinol (Oxf); 2009 Jun; 70(6):924-31. PubMed ID: 18803676
[TBL] [Abstract][Full Text] [Related]
2. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
3. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
Hamar BD; Buhimschi IA; Sfakianaki AK; Pettker CM; Magloire LK; Funai EF; Copel JA; Buhimschi CS
Am J Obstet Gynecol; 2006 Dec; 195(6):1636-45. PubMed ID: 16959203
[TBL] [Abstract][Full Text] [Related]
4. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F
Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
6. Placental and maternal serum inhibin-A and activin-A levels in Down's syndrome pregnancies.
Dalgliesh GL; Aitken DA; Lyall F; Howatson AG; Connor JM
Placenta; 2001; 22(2-3):227-34. PubMed ID: 11170828
[TBL] [Abstract][Full Text] [Related]
7. Effect of antihypertensive therapy with alpha-methyldopa on uterine artery Doppler in pregnancies with hypertensive disorders.
Khalil A; Harrington K; Muttukrishna S; Jauniaux E
Ultrasound Obstet Gynecol; 2010 Jun; 35(6):688-94. PubMed ID: 20201113
[TBL] [Abstract][Full Text] [Related]
8. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
10. Inhibins and activins in human fetal abnormalities.
Lambert-Messerlian GM; Pinar H; Laprade E; Tantravahi U; Schneyer A; Canick JA
Mol Cell Endocrinol; 2004 Oct; 225(1-2):101-8. PubMed ID: 15451574
[TBL] [Abstract][Full Text] [Related]
11. Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders.
Khalil A; Muttukrishna S; Harrington K; Jauniaux E
PLoS One; 2008 Jul; 3(7):e2766. PubMed ID: 18648513
[TBL] [Abstract][Full Text] [Related]
12. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the villous tissue of miscarriage patients.
Muttukrishna S; Bearfield C; Johns J; Jauniaux E
Mol Hum Reprod; 2004 Nov; 10(11):793-8. PubMed ID: 15361555
[TBL] [Abstract][Full Text] [Related]
13. First trimester levels of inhibins and activin A in normal and failing pregnancies.
Wallace EM; Marjono B; Tyzack K; Tong S
Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
[TBL] [Abstract][Full Text] [Related]
14. [Inhibins and Activin A in hypertensive Disorders of Pregnancy and HELLP-Syndrome].
Seufert R; Neubert S; Tanner B; Schaffrath M; Pollow K; Kölbl H
Zentralbl Gynakol; 2004 Jun; 126(3):148-53. PubMed ID: 15236099
[TBL] [Abstract][Full Text] [Related]
15. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
[TBL] [Abstract][Full Text] [Related]
16. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
Florio P; Torricelli M; De Falco G; Leucci E; Giovannelli A; Gazzolo D; Severi FM; Bagnoli F; Leoncini L; Linton EA; Petraglia F
J Hypertens; 2006 Sep; 24(9):1831-40. PubMed ID: 16915033
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relationship between activin A, follistatin and preeclampsia].
Zhao L; Shang T; Wang YL; Tang S; Li H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):676-9. PubMed ID: 14728855
[TBL] [Abstract][Full Text] [Related]
18. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension.
Sandrim VC; Palei AC; Luizon MR; Izidoro-Toledo TC; Cavalli RC; Tanus-Santos JE
Pharmacogenomics J; 2010 Feb; 10(1):40-5. PubMed ID: 19704415
[TBL] [Abstract][Full Text] [Related]
19. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R; Casagrandi D; Livanos P; Tetteh A; Nicolaides KH
Prenat Diagn; 2009 Oct; 29(10):934-8. PubMed ID: 19565609
[TBL] [Abstract][Full Text] [Related]
20. In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.
Gangooly S; Muttukrishna S; Jauniaux E
PLoS One; 2014; 9(9):e107644. PubMed ID: 25251016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
